Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PledOx with FOLFOX6 in metastatic colorectal cancer
NCT01619423Phase 2Completed
- Sponsor
- Egetis Therapeutics
- Start
- Sep 2012
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of calmangafodipir in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Egetis Therapeutics. Started Sep 2012; status: completed.
02
Drugs
calmangafodipir
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT01619423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01619423.